Utilization of Sacubitril/Valsartan in Real-World Settings

Am J Cardiovasc Drugs. 2020 Dec;20(6):619-623. doi: 10.1007/s40256-020-00433-x.

¹ Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA. [email protected].
² Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
³ Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.

No abstract available

Publication types